Stockholders’ Equity and Stock Option Plans (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

	Stock Options
	Number of Shares Underlying Outstanding Options	Weighted-Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Outstanding — December 31, 2021	6,542,351	$	6.08	6.95	$	184,727
Options granted	417,016	26.64
Options exercised	(130,958)	3.68
Options canceled/expired	(4,169)	5.74
Outstanding — March 31, 2022	6,824,240	$	7.39	6.91	$	135,005
Vested and exercisable — March 31, 2022	4,513,131	$	3.94	6.06	$	102,130

A summary of RSU activity under the Company’s equity incentive plan and related information is as follows:

	RSUs
	Number of Shares	Weighted-Average Grant Date Fair Value per Share
Unvested — December 31, 2021	483,302	$	35.23
Granted	1,060,425	28.43
Vested	(25,033)	37.29
Canceled/Forfeited	(8,838)	33.53
Unvested — March 31, 2022	1,509,856	$	30.43

Share-based Payment Arrangement, Expensed and Capitalized, Amount

The total stock-based compensation recognized in the condensed consolidated statements of operations and comprehensive income is as follows (in thousands):

	Three Months Ended March 31,
	2022		2021
Cost of revenue	$	278	$	168
Technology and development	877		481
Sales and marketing	1,907		1,161
General and administrative	2,074		1,355
Total stock-based compensation	5,136		3,165
Tax benefit from stock-based compensation	(831)		(251)
Total stock-based compensation, net of tax effect	$	4,305	$	2,914